Quickly read China
(Beijing / Shanghai Comprehensive News) China has two more crown vaccines obtained clinical trial permits, and R & D enterprises have large -scale production capacity and have been prepared for emergency use.
China CCTV learned from the scientific research team of the China State Council ’s joint defense and control mechanism yesterday that the two Chinese crown diseases have obtained the clinical trial permit for the first and second phase of the merger.Development of Vitamin Technology Co., Ltd. Joint scientific research institution.These two enterprises have a large -scale activity vaccine production capacity. According to Chinese laws and regulations, they have been prepared for emergency use.
Activated vaccines can kill pathogenic microorganisms but still maintain their immuneness, can be used for large -scale vaccination, and have international standards to judge the safety and effectiveness of the vaccine.
According to the surging news report, Wu Yuanbin, director of the Department of Social Development and Technology of the Ministry of Science and Technology of China yesterday, introduced at a press conference yesterday that the adenal virus carrier vaccine of Chen Wei team of the Chinese Academy of Engineering has completed the vaccination of the first phase of the clinical trial at the end of March and in 4On the 9th, the second phase of clinical trial volunteers began, becoming the world's first coronary vaccine to launch the second phase of clinical research.
